Pharm influenza drugs: Difference between revisions
Jump to navigation
Jump to search
Ttenbergen (talk | contribs) mNo edit summary |
Ttenbergen (talk | contribs) |
||
| Line 20: | Line 20: | ||
See [[Influenza_in_ICD10#suspected]] for more info on normal treatment course lengths. | See [[Influenza_in_ICD10#suspected]] for more info on normal treatment course lengths. | ||
== {{ | == {{CCMDB Data Integrity Checks|needs review}} == | ||
See [[Influenza_in_ICD10#CCDMB_Data_Integrity_Checks]] | See [[Influenza_in_ICD10#CCDMB_Data_Integrity_Checks]] | ||
Revision as of 00:34, 22 November 2017
| Data Element (edit) | |
| Field Name: | pharm_influenza drugs |
| CCMDB Label: | pharm_influenza drugs |
| CCMDB tab: | Pharm |
| Table: | L_Log |
| Data type: | boolean |
| Length: | not stated |
| Program: | CC |
| Created/Raw: | Raw |
| Start Date: | 2012-01-01 |
| End Date: | 2300-01-01 |
| Sort Index: | 112 |
| Data Dependencies(Reports/Indicators/Data Elements): | No results |
True if influenza drugs were given
See Pharmacy collection for collection info.
We collect the following:
- oseltamivir (Tamiflu)
- zanamivir (Relenza)
See Influenza_in_ICD10#suspected for more info on normal treatment course lengths.